AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Scope & Guideline

Innovating Treatment Strategies for Every Condition

Introduction

Immerse yourself in the scholarly insights of AMERICAN JOURNAL OF CLINICAL DERMATOLOGY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1175-0561
PublisherADIS INT LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2000 to 2024
AbbreviationAM J CLIN DERMATOL / Am. J. Clin. Dermatol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND

Aims and Scopes

The American Journal of Clinical Dermatology aims to provide a comprehensive platform for the dissemination of advanced knowledge in dermatology, emphasizing clinical practice and research. The journal covers a wide range of topics pertinent to the field, including treatment efficacy, disease mechanisms, and patient-centered care.
  1. Clinical Efficacy and Safety of Treatments:
    The journal frequently publishes studies evaluating the clinical efficacy and safety of various dermatological treatments, including biologics, JAK inhibitors, and traditional therapies, using randomized controlled trials and real-world evidence.
  2. Innovative Diagnostic and Therapeutic Approaches:
    Research on innovative diagnostic techniques and therapeutic strategies, particularly in the context of emerging technologies like artificial intelligence and personalized medicine, is a consistent focus.
  3. Pathophysiology of Skin Diseases:
    The journal emphasizes understanding the underlying mechanisms of various skin diseases, including autoimmune conditions, inflammatory disorders, and skin cancers, providing insights that inform treatment.
  4. Patient-Centered Care and Quality of Life:
    The journal highlights the importance of patient-reported outcomes and quality of life in dermatological practice, advocating for approaches that consider the holistic impact of skin diseases on patients.
  5. Emerging Trends in Dermatology:
    The publication regularly addresses emerging trends and challenges in dermatology, including the impact of systemic diseases on skin health, the role of comorbidities, and the implications of climate change on dermatologic conditions.
The American Journal of Clinical Dermatology is witnessing a dynamic evolution in its research themes, reflecting the latest advancements and challenges in dermatology. Emerging scopes indicate a shift towards more innovative and integrative approaches to skin health.
  1. Biologics and Targeted Therapies:
    There is a significant increase in research dedicated to biologics and targeted therapies, particularly for chronic conditions like psoriasis and atopic dermatitis, highlighting their clinical efficacy and safety in diverse patient populations.
  2. Artificial Intelligence in Dermatology:
    The integration of artificial intelligence in diagnostic processes and patient management is on the rise, showcasing its potential to transform dermatological practices through enhanced accuracy and efficiency.
  3. Impact of Comorbidities on Skin Diseases:
    Emerging studies are increasingly exploring the relationship between skin conditions and systemic comorbidities, reflecting a growing understanding of how overall health influences dermatological outcomes.
  4. Personalized Medicine Approaches:
    There is a trend towards personalized medicine in dermatology, with research focusing on tailoring treatments based on individual patient characteristics, including genetic profiles and specific disease presentations.
  5. Psychosocial Aspects and Quality of Life:
    An increasing emphasis on the psychosocial aspects of skin diseases, including their impact on quality of life and mental health, indicates a broader approach to patient care that goes beyond physical symptoms.

Declining or Waning

While the journal maintains a robust focus on numerous vital areas in dermatology, certain themes have experienced a decline in prominence over recent years. These waning scopes reflect shifting priorities in research and clinical practice.
  1. Traditional Therapeutics:
    There is a noticeable decrease in publications centered around traditional dermatological treatments, such as topical corticosteroids and older systemic therapies, as newer biologics and targeted therapies gain attention.
  2. General Reviews without New Insights:
    General literature reviews lacking novel insights or updates on treatment paradigms have become less common, as the journal increasingly favors studies that present original research findings or significant advances.
  3. Epidemiological Studies of Common Conditions:
    Research focusing on the epidemiology of common dermatological conditions appears to be waning, possibly due to a shift toward more specific and mechanistic studies that delve deeper into pathophysiology.
  4. Pharmacovigilance Studies:
    Although important, studies focused solely on pharmacovigilance and adverse event reporting are less frequently featured, as the journal prioritizes comprehensive clinical trials and real-world efficacy studies.

Similar Journals

Postepy Dermatologii i Alergologii

Championing open access to vital health insights.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1642-395XFrequency: 6 issues/year

Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.

Journal of Cutaneous Immunology and Allergy

Fostering collaboration for a deeper understanding of skin-related allergies.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 6 issues/year

The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

Przeglad Dermatologiczny

Pioneering Insights in Skin Science and Care
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0033-2526Frequency: 6 issues/year

Przeglad Dermatologiczny is a peer-reviewed open-access journal published by TERMEDIA PUBLISHING HOUSE LTD, based in Poland. Since its establishment in 1951, this journal has been dedicated to advancing the field of dermatology by providing a platform for the dissemination of original research, reviews, and clinical case studies. With an e-ISSN of 2084-9893, it has gained recognition within the academic community, despite its current classification in the Q4 quartile of dermatological journals. The journal has been openly accessible since 2009, promoting wider dissemination of scientific knowledge, and is crucial for researchers, professionals, and students alike. While it holds a current rank of #105 out of 142 in the Scopus Dermatology category, the journal continually strives to enhance its impact through quality publications that address pressing dermatological issues. The diverse range of topics covered in the journal ensures it remains a vital resource for those looking to stay informed on the latest developments in dermatological research.

DERMATOLOGIC CLINICS

Leading the Way in Dermatology: Where Research Meets Practice
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8635Frequency: 4 issues/year

DERMATOLOGIC CLINICS is a leading journal in the field of dermatology, published by W B SAUNDERS CO-ELSEVIER INC. Since its inception in 1983, the journal has consistently provided a platform for the dissemination of high-quality research and clinical insights, earning its place in the prestigious Q1 quartile for dermatology in 2023. With a Scopus ranking of #34 out of 142 in its category and a commendable 76th percentile, DERMATOLOGIC CLINICS remains essential reading for clinicians, researchers, and students alike. The journal features comprehensive reviews and original articles that address the latest advancements and challenges in dermatologic diagnostics and treatments. Though it does not offer Open Access, it is widely accessible ensuring a broad readership. With a commitment to advancing the understanding of skin disorders, DERMATOLOGIC CLINICS continues to uphold its legacy of excellence in dermatological scholarship.

JOURNAL OF DERMATOLOGICAL SCIENCE

Advancing the Frontiers of Skin Science
Publisher: ELSEVIER IRELAND LTDISSN: 0923-1811Frequency: 12 issues/year

The Journal of Dermatological Science is a premier peer-reviewed publication dedicated to advancing knowledge in the field of dermatology, biochemistry, and molecular biology. Established in 1990 and published by Elsevier Ireland Ltd, this esteemed journal has consistently achieved high academic recognition, securing a Q1 ranking in Dermatology and a Q2 ranking in both Biochemistry and Molecular Biology as of 2023. With a notable impact factor and a Scopus rank that places it within the top tier of dermatology journals globally, it serves as a critical platform for researchers, clinicians, and academicians to disseminate their findings and foster innovation in skin health and disease management. Although the journal is not open access, it provides essential insights into cutting-edge research, clinical practices, and molecular mechanisms underlying dermatological conditions. The Journal of Dermatological Science is not only a vital resource for high-quality articles but also a driving force in shaping the future landscape of dermatological research.

DERMATOLOGY

Pioneering research, transforming skin health.
Publisher: KARGERISSN: 1018-8665Frequency: 6 issues/year

DERMATOLOGY, an esteemed journal published by KARGER, is a vital resource in the field of dermatological research and clinical practice. Established in 1893, with its comprehensive coverage extending to 2024, this journal has earned its place as a leading publication, holding a prestigious Q1 quartile ranking in Dermatology and ranking 15th out of 142 in the Scopus Medicine - Dermatology category, reflecting its 89th percentile standing within the discipline. The journal aims to disseminate innovative research findings, critical reviews, and clinical studies that advance the understanding of skin disorders and their treatments. While primarily available through institutional subscriptions, DERMATOLOGY remains committed to enhancing accessibility and fostering international collaboration among researchers, professionals, and students in the dermatological community. Its rigorous peer-review process guarantees the highest quality of published works, making it an essential reference for those dedicated to advancing dermatological science and improving patient care.

Indian Journal of Paediatric Dermatology

Advancing knowledge in children's skin health.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2319-7250Frequency: 4 issues/year

Indian Journal of Paediatric Dermatology (ISSN: 2319-7250; E-ISSN: 2319-7269), published by Wolters Kluwer Medknow Publications, stands as a pivotal resource in the specialized field of paediatric dermatology. As a peer-reviewed open access journal since 2013, it aims to disseminate cutting-edge research, clinical practices, and innovative developments that cater to the specific dermatological needs of children. The journal provides an essential forum for collaboration among researchers, clinicians, and students, facilitating the sharing of knowledge on a wide array of topics, including skin conditions unique to paediatric populations, treatment methodologies, and advancements in dermatological care. With a commitment to enhancing the understanding and treatment of paediatric skin diseases, this journal plays a critical role in shaping best practices and informing future research directions in a rapidly evolving field.

ANAIS BRASILEIROS DE DERMATOLOGIA

Advancing Dermatological Knowledge, One Article at a Time.
Publisher: ELSEVIER SCIENCE INCISSN: 0365-0596Frequency: 6 issues/year

ANAIS BRASILEIROS DE DERMATOLOGIA is a prestigious academic journal published by Elsevier Science Inc, specializing in the dynamic field of dermatology. With its Open Access model established in 2002, this journal ensures wide dissemination of research findings and facilitates collaboration within the dermatological community. Hailing from Brazil, it provides a platform for innovative research from both local and international contributors, spanning from its inception in 1963 to the current year, 2024. The journal positions itself as a vital resource in the dermatology sphere, currently ranked in the Q3 category for dermatology and holding a notable rank of 71 out of 142 in the Scopus rankings, placing it in the 50th percentile for its field. With a commitment to advancing knowledge and practice in dermatology, ANAIS BRASILEIROS DE DERMATOLOGIA is an essential read for researchers, professionals, and students eager to explore contemporary advancements and clinical practices.

INTERNATIONAL JOURNAL OF DERMATOLOGY

Advancing dermatological science for a healthier tomorrow.
Publisher: WILEYISSN: 0011-9059Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF DERMATOLOGY, published by WILEY, stands as a premier scholarly platform in the field of dermatology, with a notable impact factor that affirms its quality and renown. Established in 1963 and converging through to 2024, this journal is recognized as a Q1 category publication, ranking in the top 20% of journals within the dermatology field according to the Scopus ranking system, where it occupies the 28th position among 142 journals. This reflects its dedication to advancing the understanding and treatment of skin diseases, making it a vital resource for researchers, healthcare professionals, and medical students alike. Although it does not provide open access options, articles published in this journal cover a broad range of dermatological topics, ensuring that it serves as a comprehensive and authoritative source for cutting-edge research and clinical practices. With its rigorous peer-review process and commitment to high standards, the INTERNATIONAL JOURNAL OF DERMATOLOGY remains indispensable for those engaged in dermatological science and practice.

Actas Dermo-Sifiliograficas

Championing Open Access to Dermatological Excellence
Publisher: ELSEVIER ESPANAISSN: 0001-7310Frequency: 10 issues/year

Actas Dermo-Sifiliograficas, published by Elsevier España, stands as a pivotal resource in the realms of dermatology, histology, and pathology and forensic medicine. With its ISSN of 0001-7310 and E-ISSN 1578-2190, this esteemed journal has transitioned to an Open Access model since 2020, facilitating broader dissemination of impactful research. Operating from its Madrid headquarters, it has been a vital platform for scholarly exchange since its inception in 1945, continuing through its converged years until 2024. The journal holds a Q3 ranking in dermatology, histology, and pathology and forensic medicine as of 2023, reflecting its relevance in the academic community where it ranks 79th in dermatology and 126th in pathology among its peers. With a commitment to advancing knowledge and practice in its fields, Actas Dermo-Sifiliograficas serves as an essential repository for researchers, professionals, and students seeking to engage with the latest findings and innovative perspectives in skin and disease research.